{"id":"https://openalex.org/W4379338738","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.tps8603","title":"Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).","display_name":"Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).","publication_year":2023,"publication_date":"2023-06-01","ids":{"openalex":"https://openalex.org/W4379338738","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.tps8603"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2023.41.16_suppl.tps8603","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.tps8603","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.tps8603","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071440718","display_name":"Aaron Scott Mansfield","orcid":"https://orcid.org/0000-0002-9483-6903","observed_orcids":["https://orcid.org/0000-0002-9483-6903"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron Scott Mansfield","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103179336","display_name":"Austin W. Goodrich","orcid":"https://orcid.org/0009-0008-5596-0873","observed_orcids":["https://orcid.org/0009-0008-5596-0873"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Austin Goodrich","raw_affiliation_strings":["Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008026182","display_name":"Nathan R. Foster","orcid":"https://orcid.org/0000-0002-2874-1295","observed_orcids":["https://orcid.org/0000-0002-2874-1295"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathan R. Foster","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Panos Savvides","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Panos Savvides","raw_affiliation_strings":["Mayo Clinic Arizona, Phoenix, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Arizona, Phoenix, AZ","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082389042","display_name":"Liza Cosca Villaruz","orcid":"https://orcid.org/0000-0001-7456-523X","observed_orcids":["https://orcid.org/0000-0001-7456-523X"]},"institutions":[{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liza C Villaruz","raw_affiliation_strings":["University of Pittsburgh Medical Center, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Medical Center, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210134769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059543131","display_name":"Patrick M. Forde","orcid":"https://orcid.org/0000-0001-6925-6344","observed_orcids":["https://orcid.org/0000-0001-6925-6344"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick M. Forde","raw_affiliation_strings":["Johns Hopkins Medicine, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins Medicine, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032970786","display_name":"Kanwal P. S. Raghav","orcid":"https://orcid.org/0000-0003-1311-4173","observed_orcids":["https://orcid.org/0000-0003-1311-4173"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kanwal Pratap Singh Raghav","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054605021","display_name":"Paul Bernard Romesser","orcid":"https://orcid.org/0000-0001-8268-2903","observed_orcids":["https://orcid.org/0000-0001-8268-2903"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Bernard Romesser","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Diane Feldman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diane Feldman","raw_affiliation_strings":["Alliance Protocol Operations Office, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alliance Protocol Operations Office, Chicago, IL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061216888","display_name":"Liang Cao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liang Cao","raw_affiliation_strings":["NCI, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NCI, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004022151","display_name":"Mary M. Salvatore","orcid":"https://orcid.org/0000-0002-1429-5749","observed_orcids":["https://orcid.org/0000-0002-1429-5749"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary M. Salvatore","raw_affiliation_strings":["Department of Radiology, Columbia University Irving Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiology, Columbia University Irving Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034226178","display_name":"Anja Christiane Roden","orcid":"https://orcid.org/0000-0001-8948-4758","observed_orcids":["https://orcid.org/0000-0001-8948-4758"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anja C. Roden","raw_affiliation_strings":["Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073432388","display_name":"Steven Francis Powell","orcid":"https://orcid.org/0000-0002-5029-0048","observed_orcids":["https://orcid.org/0000-0002-5029-0048"]},"institutions":[{"id":"https://openalex.org/I1305840828","display_name":"Sanford Health","ror":"https://ror.org/003smky23","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1305840828"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Francis Powell","raw_affiliation_strings":["Sanford Health, Sioux Falls, SD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanford Health, Sioux Falls, SD","institution_ids":["https://openalex.org/I1305840828"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079795657","display_name":"Ardaman P. Shergill","orcid":"https://orcid.org/0000-0002-8244-2704","observed_orcids":["https://orcid.org/0000-0002-8244-2704","https://orcid.org/0000-0003-0675-7760"]},"institutions":[{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ardaman Shergill","raw_affiliation_strings":["Department of Medicine, Section of Hematology & Oncology, University of Chicago Medical Center, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Section of Hematology & Oncology, University of Chicago Medical Center, Chicago, IL","institution_ids":["https://openalex.org/I4210087865"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083373965","display_name":"Pamela N. M\u00fcnster","orcid":"https://orcid.org/0000-0002-2074-0984","observed_orcids":["https://orcid.org/0000-0002-2074-0984","https://orcid.org/0009-0009-4141-2312"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pamela N. Munster","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006913373","display_name":"Gary K. Schwartz","orcid":"https://orcid.org/0000-0003-1813-5061","observed_orcids":["https://orcid.org/0000-0003-1813-5061"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary K. Schwartz","raw_affiliation_strings":["Columbia University Irving Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University Irving Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035664172","display_name":"Travis Edward Grotz","orcid":"https://orcid.org/0000-0002-7753-097X","observed_orcids":["https://orcid.org/0000-0002-7753-097X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Travis Edward Grotz","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"41","issue":"16_suppl","first_page":"TPS8603","last_page":"TPS8603"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11026","display_name":"Occupational and environmental lung diseases","score":0.5127000212669373,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11026","display_name":"Occupational and environmental lung diseases","score":0.5127000212669373,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.4828999936580658,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/peritoneal-mesothelioma","display_name":"peritoneal mesothelioma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.8640000224113464},{"id":"https://openalex.org/keywords/palliative-chemotherapy","display_name":"palliative chemotherapy","score":0.9380000233650208},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.8029999732971191},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9340000152587891},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.8889999985694885},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.9440000057220459},{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":1.0},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.7639999985694885},{"id":"https://openalex.org/keywords/chemoimmunotherapy","display_name":"chemoimmunotherapy","score":0.8399999737739563},{"id":"https://openalex.org/keywords/unresectable-disease","display_name":"unresectable disease","score":0.6399999856948853},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.43299999833106995},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.47099998593330383},{"id":"https://openalex.org/keywords/pleural-mesothelioma","display_name":"pleural mesothelioma","score":0.6549999713897705}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9455618858337402},{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.8618975281715393},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8169721961021423},{"id":"https://openalex.org/C2778995398","wikidata":"https://www.wikidata.org/wiki/Q7168876","display_name":"Peritoneal mesothelioma","level":3,"score":0.7620118260383606},{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.681083083152771},{"id":"https://openalex.org/C2777407522","wikidata":"https://www.wikidata.org/wiki/Q1077603","display_name":"Mesothelioma","level":2,"score":0.661231279373169},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.6588056087493896},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6428468227386475},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6049152612686157},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4186226427555084},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.41795989871025085},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.3631613254547119},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2575073540210724},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.20609989762306213},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1577681601047516},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.07488545775413513}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2023.41.16_suppl.tps8603","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.tps8603","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.tps8603","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3032213107","https://openalex.org/W4399451788","https://openalex.org/W4410816368","https://openalex.org/W4403461662","https://openalex.org/W4282031897","https://openalex.org/W4307688941","https://openalex.org/W2801311742","https://openalex.org/W2891461173","https://openalex.org/W2590400399","https://openalex.org/W4406969257"],"abstract_inverted_index":{"TPS8603":[0],"Background:":[1],"Peritoneal":[2],"mesothelioma":[3,36,165],"is":[4,151,238,365],"a":[5,68,152,171,252,294],"rare":[6],"and":[7,52,80,106,115,134,180,222,248,261,322,332,345,364],"poorly":[8],"studied":[9],"disease":[10,232],"with":[11,41,76,91,104,113,132,138,161,182,198,216,227,244,293,350],"few":[12],"treatment":[13,23,62,243],"options.":[14],"For":[15],"patients":[16],"(pts)":[17],"who":[18,193,210],"are":[19,194,211,311],"not":[20,212],"surgical":[21],"candidates,":[22],"recommendations":[24],"for":[25,34,59,145,189,317],"systemic":[26],"therapy":[27,204],"have":[28],"been":[29,95],"extrapolated":[30],"from":[31,289],"clinical":[32,157],"trials":[33],"pleural":[35,65,98],"that":[37],"commonly":[38],"exclude":[39],"pts":[40,137,160,270,310],"peritoneal":[42,85,141,164],"mesothelioma.":[43,66,86,99,142],"Recently,":[44],"the":[45,48,53,60,101,107,123,126,287,358,370],"combination":[46],"of":[47,63,125,203,231,298],"PD-1":[49],"inhibitor":[50,55,128],"nivolumab":[51],"CTLA-4":[54],"ipilimumab":[56],"received":[57],"FDA-approval":[58],"frontline":[61,242],"non-resectable":[64],"Additionally,":[67],"prospective,":[69,153],"non-randomized":[70],"phase":[71,155],"2":[72,156],"trial":[73,353,373],"demonstrated":[74],"activity":[75,90],"combined":[77,92],"PD-L1":[78,127],"(atezolizumab)":[79],"VEGF":[81,116],"(bevacizumab)":[82],"blockade":[83],"in":[84,97,136,148,251,286],"In":[87],"parallel,":[88],"encouraging":[89],"chemo-immunotherapy":[93],"has":[94,279],"reported":[96],"Given":[100],"benefits":[102],"observed":[103],"immunotherapy,":[105],"potential":[108],"to":[109,120,176,196,214,239,258,282,291],"improve":[110],"upon":[111],"those":[112],"chemotherapy":[114,133],"inhibition,":[117],"we":[118,338],"seek":[119],"determine":[121,240,340],"whether":[122],"addition":[124],"atezolizumab":[129,226,249],"improves":[130],"outcomes":[131],"bevacizumab":[135,221,228,247,262],"newly":[139,162],"diagnosed":[140,163],"Methods:":[143],"Alliance":[144],"Clinical":[146,372],"Trials":[147],"Oncology":[149],"A092001":[150],"randomized":[154,168,277],"trial.":[158],"All":[159],"will":[166,205,305,339],"be":[167,306],"1:1":[169],"using":[170],"dynamic":[172],"allocation":[173],"Pocock-Simon":[174],"procedure":[175],"receive":[177,219],"carboplatin,":[178,245,259],"pemetrexed":[179,260],"bevacizumab,":[181],"or":[183,224,233],"without":[184],"atezolizumab,":[185,223],"every":[186],"21":[187],"days":[188],"four":[190,201],"cycles.":[191],"Patients":[192],"eligible":[195,213,269,274],"proceed":[197,215],"surgery":[199,217,319],"after":[200,308],"cycles":[202],"then":[206],"do":[207],"so.":[208],"Pts":[209],"may":[218],"maintenance":[220],"second-line":[225],"until":[229],"progression":[230],"toxicity.":[234],"The":[235],"primary":[236],"objective":[237],"if":[241,341],"pemetrexed,":[246],"results":[250],"superior":[253],"best":[254],"response":[255],"rate":[256],"(RR)":[257],"as":[263],"determined":[264],"by":[265,357],"RECIST.":[266],"With":[267],"31":[268],"per":[271],"arm":[272],"(62":[273],"total),":[275],"this":[276],"design":[278],"80%":[280],"power":[281],"detect":[283],"an":[284,301],"improvement":[285],"RR":[288],"20%":[290],"45%,":[292],"1-sided":[295],"significance":[296],"level":[297],"0.10":[299],"where":[300],"interim":[302],"futility":[303],"analysis":[304],"conducted":[307],"32":[309],"enrolled.":[312],"Stratification":[313],"factors":[314],"include":[315,327],"eligibility":[316],"cytoreductive":[318],"at":[320,367],"diagnosis":[321],"histologic":[323],"subtype.":[324],"Secondary":[325],"endpoints":[326],"progression-free":[328],"survival,":[329],"overall":[330],"survival":[331],"adverse":[333],"events.":[334],"As":[335],"integrated":[336],"biomarkers,":[337],"soluble":[342],"mesothelin-related":[343],"peptides":[344],"megakaryocyte":[346],"potentiating":[347],"factor":[348],"correlate":[349],"responses.":[351],"This":[352],"was":[354],"recently":[355],"approved":[356],"National":[359],"Cancer":[360],"Institute":[361],"Central":[362],"IRB":[363],"activating":[366],"sites":[368],"across":[369],"country.":[371],"information:":[374],"NCT05001880":[375],".":[376]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2023-06-05T00:00:00"}